The Team
We are successful financiers, investors, entrepreneurs with CEO experience in the European and American medical sector. We have a proven track record in identifying, structuring, financing and managing medical companies.
Herbert L. Oakes, Jr. is an investment banker, venture capitalist and
serial entrepreneur. In addition to financing over fifty public and
private companies at Oakes Lyman and its predecessor, Oakes Fitzwilliams, he
has completed a number of corporate transactions, including the collaboration
between Xenova and Genentech; the sale of Psygnosis to Sony; and the disposals
by Olivetti S.p.A. of its personal computer and printed circuit board
businesses. He has been a director and/or chairman
of a number of publicly held companies in the
Richard P. Lyman is
a venture capitalist, corporate executive, and serial entrepreneur. In
1979, after a period as president of Squibb’s Medical Systems International
Group, he joined the venture capital firm Adler & Co. where he assembled
and managed the healthcare portfolio that included a controlling interest in
Biotechnology General, Inc. (chairman and CEO); and Life Technologies, Inc.
(chairman and CEO), now an integral part of Invitrogen. In 1985, he
raised and was managing partner of Healthcare Ventures 1, the then largest life
science venture fund in the
Dr. Jakob (“Jaap”) Kampinga, is a medical doctor, academic scientist, and serial entrepreneur. He became the R&D director of Quadrant Healthcare plc in 1994. Quadrant floated on the London Stock Exchange in 1998 and was acquired by Elan Pharmaceuticals in 2000. Dr. Kampinga was an executive director and a key member of the team that promoted the initial public offering. He was the founder of Jari Pharmaceuticals BV.
Howard Miller, is a medical scientist and a highly respected
securities analyst. In 2000, he became a life science equities research
analyst at the specialist small-cap